Article info
Original Article
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer
- Correspondence to Dr Yolanda Garcia Garcia, Oncología Médica, Parc Taulí Hospital Universitari, Sabadell 08208, Spain; ygarcia{at}tauli.cat
Citation
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer
Publication history
- Received January 24, 2019
- Revision received May 20, 2019
- Accepted May 23, 2019
- First published July 1, 2019.
Online issue publication
November 18, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.